Tj Cradick, Ph.D.
AeroLeads people directory · profile

Tj Cradick, Ph.D. Email & Phone Number

CSO and Principal at Gene Editing Frontiers LLC
Location: Cambridge, Massachusetts, United States 21 work roles 5 schools
1 work email found @crisprtx.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email t****@crisprtx.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CSO and Principal
Location
Cambridge, Massachusetts, United States

Who is Tj Cradick, Ph.D.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Tj Cradick, Ph.D. is listed as CSO and Principal at Gene Editing Frontiers LLC, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at crisprtx.com and a matched LinkedIn profile for Tj Cradick, Ph.D..

Tj Cradick, Ph.D. previously worked as Chief Technology Officer at Huidagene Therapeutics and CSO / Principal at Gene Editing Frontiers Llc. Tj Cradick, Ph.D. holds Ph.D., Molecular And Cellular Biology from University Of Iowa.

Company email context

Email format at Gene Editing Frontiers LLC

This section adds company-level context without repeating Tj Cradick, Ph.D.'s masked contact details.

*@crisprtx.com
68% confidence

AeroLeads found 1 current-domain work email signal for Tj Cradick, Ph.D.. Compare company email patterns before reaching out.

Profile bio

About Tj Cradick, Ph.D.

TJ Cradick PhD is the Chief Technology Officer (CTO) at HuidaGene Therapeutics, a global, clinical-stage biotech company that has developed a number of propriatary gene editing toolsIn additions the other positions, TJ consults on CRISPR, Gene Editing, and Epigenetic, building and advising new Gene Editing companies. See consulting info, my papers and presentations athttps://GeneEditingFrontiers.comPreviously, TJ Cradick was the Chief Scientific Officer (CSO) at Excision BioTherapeutics, a clinical-stage biotech company that is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. TJ led Excision's scientific vision and strategy, oversaw the research and development of its pipeline projects, and managed collaborations with academic and industry partners. TJ is the former Head of Genome Editing at CRISPR Therapeutics. As the 2nd US CRISPR Tx employee, he had many responsibilities through the company’s progression to a clinical stage company with >300 employees. TJ was faculty and Director of the Protein Engineering Facility at the Georgia Institute of Technology, where the research included bioinformatics and assays for CRISPR / Cas9 on- & off-target events.TJ is a recognized leader and innovator in the field of CRISPR/Cas9 technology, having published several influential papers on its applications, mechanisms, and optimization. He is also a Scientific Advisory Board Member at Eucalyptus Bio (CRISP-HR Therapeutics, Inc.) and at Catalytic Data Science. TJ is passionate about advancing the science and practice of CRISPR/Cas9 to address unmet medical needs and transform the lives of patients.

Listed skills include Cell, Molecular Biology, Protein Chemistry, Biochemistry, and 43 others.

Current workplace

Tj Cradick, Ph.D.'s current company

Company context helps verify the profile and gives searchers a useful next step.

Gene Editing Frontiers LLC
Gene Editing Frontiers Llc
CSO and Principal
Cambridge, MA, US
AeroLeads page
21 roles · 41 years

Tj Cradick, Ph.D. work experience

A career timeline built from the work history available for this profile.

Cso / Principal

Current

https://GeneEditingFrontiers.com Providing fractional CSO functions, plus a consultant & advisor on all aspects of Gene Editing, Gene & Cell Therapy, including CRISPR, TALENS, Zinc Finger Nucleases, Base Editing and Gene Writing, Bioinformatics & Computational Biology (including CRISPR off-target assays) and FDA filings.Strategy, experimental design, due.

Apr 2024 - Present

Scientific Advisory Board Member

Current
Eucalyptus Bio

Independent Scientific Advisory Board member.

Oct 2020 - Present

Scientific Advisory Board Member

Current

Charleston, South Carolina, US

Independent Scientific Advisory Board member.

Jul 2020 - Present

Chief Scientific Officer (Cso)

San Francisco, CA, US

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. Excision EBT-101 clinical trial for HIV was awarded Fast Track designation and continues to enroll. Pipeline projects include HIV, HBV, and HSV. https://www.Excision.Bio/

Jul 2021 - Nov 2023

Strategic Advisor

Consultant & Advisor on Gene Editing, Gene & Cell Therapy.CRISPR, TALENS, Zinc Finger Nucleases. Bioinformatics & Computational Biology. Strategy, experimental design, due diligence, IP.

Jan 2020 - Feb 2021

Head Of Genome Editing

Boston, MA, US

Head of Genome Editing and 2nd U.S. employee. CRISPR Therapeutics is translating CRISPR-Cas9, a breakthrough genome-editing technology, into transformative medicines to cure human diseases. Mutations in genes that are causing diseases are specifically targeted by CRISPR-Cas9 and repaired using the cellular repair machinery. Research in the Genome Editing.

Mar 2015 - Nov 2019

Director Of Protein Engineering Facility

Atlanta, Georgia, US

♦ Developed CRISPR gene editing technologies, including methods to characterized nuclease specificity to drive further improvements. This research resulted in 21 publications and book chapters (so far), plus several patents (see below).♦ Developed and patented exhaustive CRISPR on- and off-target search method, including mismatches and /or differences in.

Apr 2011 - Mar 2015

Biotech / Patent Consultant

Biotechnology Consulting

Molecular and cell biology consulting (genetics, recombination, cloning and expression systems, assay development) for local and international clients.

2010 - 2011 ~1 yr

Co-Owner, Scientific Advisor

Protein Delivery Startup

♦ Started as consultant, then given equity.♦ Advised on molecular and cellular biology methods and technology, protein engineering, literature, and filings for a biotech startup company focused on gene and gene therapy delivery.♦ Wrote declaration and contributed to the patent filings.

2009 - 2010 ~1 yr

Postdoctoral Fellow, Zinc Finger Nuclease Design & Testing

Iowa City, Iowa, US

Developed 14 sets of validated Zinc Finger Nucleases to create disease models in Cell Lines, Rat, Mice and Zebrafish.Set up cloning for Viral Vectors for our Zinc Finger Nucleases.Developed Bioinformatics and web interface that designs Zinc Finger Nucleases that target user-specified gene segments.ZFN-Site searches genomes for zinc finger nuclease target.

2009 - 2010 ~1 yr

Phd Student To Post Doc, Zinc Finger Nuclease Design, Testing And Development

Iowa City, Iowa, US

Developed Zinc Finger Nucleases (ZFNs) that specifically cleave Hepatitis B Viral (HBV) DNA. Developed ZFN-site bioinformatic tool to help design zinc finger proteins and scan genomes for possible on-target and off-target sites. Developed assays to measure cleavage and mis-repair of ZFN sites and off-target sites:One of two groups to develop and first.

2004 - 2009 ~5 yrs

Associate Scientist Ii, Zinc Finger Design & Selection Group

Brisbane, California, US

  • Part of Zinc Finger and Zinc Finger Nuclease design (protein engineering) and selection group charged with producing DNA-binding domains with high activity and specificity.
  • Developed new in vitro display selection technologies. Selected and tested ZFPs using Bacterial Two-Hybrid, SELEX and other systems.
  • Chose genomic targets using Bioinformatics, Southern Analysis and DNase Hypersensitivity Mapping.
  • Constructed artificial transcription factors with ZFPs fused to Activation and/or Repression Domains, transfected cells, and prepared RNA for analysis. Improved standard protocols and help troubleshoot these processes.
  • Designed and optimized Taqman Primers and Probes and quantitated resulting changes in mRNA expression using Taqman and Affymetrix. Further analyzed the role our molecules played in gene regulation using Bioinformatic.
  • Biochemical studies of ZFPs, including Gel-Shift and Off-Rate experiments and Alanine Screens.AC Jamieson, Bo Guan, TJ Cradick, H Xiao, PD Gregory and PM Carroll. Controlling gene expression in transgenic Drosophila.
2000 - 2004 ~4 yrs

Phage Display For High-Throughput Screening

US

Designed and developed a novel series of phage display libraries for use in high-throughput cellular assays.

1998 - 1999 ~1 yr

Phd Student In Immunology And Microbiology, Developing Proteolytic Antibodies

San Francisco, California, US

  • Thesis: Selection of Proteolytic Antibodies Against HIV gp120 (Advisor, Dr. Matthias Wabl).
  • Developed Novel Phage-Based Selection for proteolytic antibodies. Tested via HPLC.
  • Devised method to screen very large Antibody Libraries:
  • Cloned Very Large Phage Display Antibody Libraries, both naïve and from mice I immunized with transition-state analogs.
  • Assisted with troubleshooting email-based querying of Kabat Immunologic gene database for V-region primer design and other projects.
1993 - 1998 ~5 yrs

Immunology Consultant For Law Firm

Ropers, Majeski, Kohn & Bentley
  • Immunology consultant for law office handling cases of individuals with suspected autoimmune responses to breast implants.
  • Advised on literature, methods, current research, and possible further experimentation.
1996 - 1996

Research Associate, Hiv Reseach, Phage Display & Drug Discovery

Waltham, MA, US

  • Brought in-house, developed and optimized a phage display library system and wrote SOPs for mapping the binding domains of anti-HIV antibodies and cell surface proteins. Screened phage displayed peptide libraries for.
  • Engineered and expressed fusion proteins, and developed a phage expression system for structure/function analysis of protein domains for small molecule drug discovery.
  • Prepared HIV clones using Long PCR for syncitia formation and neutralization assays.CL Jellis, TJ Cradick, P Rennert, P Salinas, J Boyd, T Amirault and GS Gray. Defining critical residues in the epitope for a.
1989 - 1993 ~4 yrs

Research Associate, Diabetes Research, Molecular Biology Lab

Boston, Massachusetts, US

  • May 1988 - Oct. 1989
  • Effects of SV40 large T and small t antigens on transcriptional control.
  • Operation of, and training others for use with the molecular core facility.
  • Rebuilt and operated the oligo. synthesizer and assisted others with PCR primer design.
1988 - 1989 ~1 yr

Campus Tour Guide

Mit

Cambridge, MA, US

1985 - 1988 ~3 yrs

Urop Undergraduate Researcher

Mit

Cambridge, MA, US

Tested polymers for drug delivery in Robert Langer's Laboratory.

1986 - 1986
5 education records

Tj Cradick, Ph.D. education

Ph.D., Molecular And Cellular Biology

University Of Iowa

Ma, Immunology

University Of California, San Francisco

Bs, Life Sciences

Massachusetts Institute Of Technology

Semester At Queen Mary And Westfield College, Part Of The University Of London.

Queen Mary University Of London

Education record

Marist School
FAQ

Frequently asked questions about Tj Cradick, Ph.D.

Quick answers generated from the profile data available on this page.

What company does Tj Cradick, Ph.D. work for?

Tj Cradick, Ph.D. works for Gene Editing Frontiers LLC.

What is Tj Cradick, Ph.D.'s role at Gene Editing Frontiers LLC?

Tj Cradick, Ph.D. is listed as CSO and Principal at Gene Editing Frontiers LLC.

What is Tj Cradick, Ph.D.'s email address?

AeroLeads has found 1 work email signal at @crisprtx.com for Tj Cradick, Ph.D. at Gene Editing Frontiers LLC.

Where is Tj Cradick, Ph.D. based?

Tj Cradick, Ph.D. is based in Cambridge, Massachusetts, United States while working with Gene Editing Frontiers LLC.

What companies has Tj Cradick, Ph.D. worked for?

Tj Cradick, Ph.D. has worked for Gene Editing Frontiers Llc, Huidagene Therapeutics, Eucalyptus Bio, Catalytic Data Science, and Excision Biotherapeutics.

How can I contact Tj Cradick, Ph.D.?

You can use AeroLeads to view verified contact signals for Tj Cradick, Ph.D. at Gene Editing Frontiers LLC, including work email, phone, and LinkedIn data when available.

What schools did Tj Cradick, Ph.D. attend?

Tj Cradick, Ph.D. holds Ph.D., Molecular And Cellular Biology from University Of Iowa.

What skills is Tj Cradick, Ph.D. known for?

Tj Cradick, Ph.D. is listed with skills including Cell, Molecular Biology, Protein Chemistry, Biochemistry, Pcr, Drug Discovery, Laboratory, and Immunology.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.